- Home
- APLT vs AUBN Comparison
APLT vs AUBN Comparison
Compare APLT & AUBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- AUBN
- Stock Information
- Founded
- APLT 2016
- AUBN 1907
- Country
- APLT United States
- AUBN United States
- Employees
- APLT N/A
- AUBN N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- AUBN Major Banks
- Sector
- APLT Health Care
- AUBN Finance
- Exchange
- APLT Nasdaq
- AUBN Nasdaq
- Market Cap
- APLT 80.3M
- AUBN 74.7M
- IPO Year
- APLT 2019
- AUBN 1995
- Fundamental
- Price
- APLT $0.53
- AUBN $20.45
- Analyst Decision
- APLT Buy
- AUBN
- Analyst Count
- APLT 7
- AUBN 0
- Target Price
- APLT $6.10
- AUBN N/A
- AVG Volume (30 Days)
- APLT 3.0M
- AUBN 2.7K
- Earning Date
- APLT 03-05-2025
- AUBN 01-28-2025
- Dividend Yield
- APLT N/A
- AUBN 5.28%
- EPS Growth
- APLT N/A
- AUBN 359.14
- EPS
- APLT N/A
- AUBN 1.83
- Revenue
- APLT N/A
- AUBN $30,563,000.00
- Revenue This Year
- APLT N/A
- AUBN N/A
- Revenue Next Year
- APLT $2,622.90
- AUBN N/A
- P/E Ratio
- APLT N/A
- AUBN $11.17
- Revenue Growth
- APLT N/A
- AUBN 31.96
- 52 Week Low
- APLT $0.53
- AUBN $16.48
- 52 Week High
- APLT $10.62
- AUBN $25.40
- Technical
- Relative Strength Index (RSI)
- APLT 29.75
- AUBN 38.31
- Support Level
- APLT $0.54
- AUBN $20.50
- Resistance Level
- APLT $0.70
- AUBN $21.09
- Average True Range (ATR)
- APLT 0.06
- AUBN 0.33
- MACD
- APLT 0.06
- AUBN -0.01
- Stochastic Oscillator
- APLT 0.00
- AUBN 25.86
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AUBN Auburn National Bancorporation Inc.
Auburn National Bancorp Inc operates as a bank holding company, which offers checking, savings, transaction deposit accounts and certificates of deposit, and is an active residential mortgage lender in its primary service area. The Bank's primary service area includes the cities of Auburn and Opelika, Alabama and nearby surrounding areas in East Alabama, predominantly in Lee County. The Bank also offers commercial, financial, agricultural, real estate construction and consumer loan products and other financial services. The Bank also provides automated teller machine (ATM) services in East Alabama and operates ATM machines. The Bank offers Visa Checkcards, which are debit cards. The Bank offers online banking, bill payment and other electronic banking services through its Internet website.